Clinical Trials Logo

Clinical Trial Summary

Transthoracic echocardiography (TTE) is known to be an effective modality in assessing cardiac function as well as the structure of the heart. It was estimated that between 15% and 30% of ischemic strokes were due to a cardioembolic source, Therefore, TTE has been assumed as an important screening tool in patients with ischemic stroke, as atrial fibrillation is one of the leading risk factors. However, current guidelines have little evidence in whether performing TTE can alter clinical management and prevent a future stroke. We aim to present the association of performing TTE and clinical outcomes in stroke patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04788602
Study type Observational
Source National Taiwan University Hospital
Contact Wan-Ching Lien
Phone +886-23123456
Email wanchinglien@ntu.edu.tw
Status Recruiting
Phase
Start date January 1, 2019
Completion date December 31, 2023